Wahr says Nuvaira gives him a familiar feeling; lays out plans for fund-raising, commercial launch
- Author
- Healthegy
- Published
- Fri 13 Oct 2017
- Episode Link
- None
Nuvaira CEO Dennis Wahr, MD, sees similarities between interventional pulmonology today and interventional cardiology in its early days. He hopes Nuvaira, which is developing a tool to ablate lung tissue, will be able to further the field through upcoming clinical trials and fund-raising.
